Genelux Corporation
GNLXNASDAQHealthcare● Active
$2.93
+$0.00(+0.00%)
Market Cap$110217535
P/E Ratio—
52W High$8.535
52W Low$2.29
Genelux Corporation (GNLX) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
GNLX · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 7, 2026EPS Actual
-$0.20
Est. -$0.18 · -11.1%
Revenue
—
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 7, 2026
After Market Close
▼ Miss EPS
GNLX reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 6, 2026 | -$0.20 | — | — | — | — | — |
| ▼ Q2 FY2026 | May 7, 2026 | -$0.18 | -$0.20 | -11.1% | — | — | — |
| ▼ Q1 FY2026 | Mar 19, 2026 | -$0.22 | -$0.24 | -9.1% | $0.00B | $0.00B | +0.0% |
| ▲ Q4 FY2025 | Nov 5, 2025 | -$0.23 | -$0.21 | +8.7% | — | — | — |
| ▲ Q3 FY2025 | Aug 7, 2025 | -$0.22 | -$0.20 | +9.1% | — | — | — |
| ▲ Q2 FY2025 | May 6, 2025 | -$0.24 | -$0.21 | +12.5% | — | — | — |
| ▼ Q1 FY2025 | Mar 28, 2025 | -$0.17 | -$0.26 | -52.9% | $0.00B | — | — |
| — Q4 FY2024 | Nov 14, 2024 | -$0.19 | -$0.19 | +0.0% | — | — | — |
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
-$0.20
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 7, 2026Miss
EPS Actual
-$0.20
EPS Est.
-$0.18
EPS Surpr.
-11.1%
Revenue
—
Q1 FY2026
Mar 19, 2026Miss
EPS Actual
-$0.24
EPS Est.
-$0.22
EPS Surpr.
-9.1%
Revenue
$0.00B
Q4 FY2025
Nov 5, 2025Beat
EPS Actual
-$0.21
EPS Est.
-$0.23
EPS Surpr.
+8.7%
Revenue
—
Q3 FY2025
Aug 7, 2025Beat
EPS Actual
-$0.20
EPS Est.
-$0.22
EPS Surpr.
+9.1%
Revenue
—
Q2 FY2025
May 6, 2025Beat
EPS Actual
-$0.21
EPS Est.
-$0.24
EPS Surpr.
+12.5%
Revenue
—
Q1 FY2025
Mar 28, 2025Miss
EPS Actual
-$0.26
EPS Est.
-$0.17
EPS Surpr.
-52.9%
Revenue
$0.00B
Q4 FY2024
Nov 14, 2024
EPS Actual
-$0.19
EPS Est.
-$0.19
EPS Surpr.
+0.0%
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.18 | $-0.18 | $-0.18 | 2 |
| Q3 FY2027 | $-0.20 | $-0.20 | $-0.20 | 1 |
| Q2 FY2027 | $-0.25 | $-0.25 | $-0.25 | 1 |
| Q1 FY2027 | $-0.24 | $-0.24 | $-0.24 | 2 |
| Q4 FY2026 | $-0.22 | $-0.22 | $-0.22 | 2 |
| Q3 FY2026 | $-0.20 | $-0.20 | $-0.20 | 4 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 7, 2026 | -11.1% | $2.87 | $2.83 | -1.39% |
| ▼ Q1 FY2026 | Mar 19, 2026 | -9.1% | $2.59 | $2.54 | -1.93% |
| ▲ Q4 FY2025 | Nov 5, 2025 | +8.7% | $8.11 | $7.84 | -3.33% |
| ▲ Q3 FY2025 | Aug 7, 2025 | +9.1% | $3.59 | $3.34 | -6.96% |
| ▲ Q2 FY2025 | May 6, 2025 | +12.5% | $2.51 | $2.33 | -7.17% |
| ▼ Q1 FY2025 | Mar 28, 2025 | -52.9% | $3.03 | $3.08 | +1.65% |
| ▲ Q4 FY2024 | Nov 14, 2024 | +0.0% | $2.81 | $2.94 | +4.63% |
| ▼ Q3 FY2024 | Aug 14, 2024 | -15.8% | $2.06 | $2.09 | +1.46% |
Q2 FY2026-1.39%
Report Date
May 7, 2026
EPS Beat/Miss
-11.1%
Price Before
$2.87
Price After
$2.83
Q1 FY2026-1.93%
Report Date
Mar 19, 2026
EPS Beat/Miss
-9.1%
Price Before
$2.59
Price After
$2.54
Q4 FY2025-3.33%
Report Date
Nov 5, 2025
EPS Beat/Miss
+8.7%
Price Before
$8.11
Price After
$7.84
Q3 FY2025-6.96%
Report Date
Aug 7, 2025
EPS Beat/Miss
+9.1%
Price Before
$3.59
Price After
$3.34
Q2 FY2025-7.17%
Report Date
May 6, 2025
EPS Beat/Miss
+12.5%
Price Before
$2.51
Price After
$2.33
Q1 FY2025+1.65%
Report Date
Mar 28, 2025
EPS Beat/Miss
-52.9%
Price Before
$3.03
Price After
$3.08
Q4 FY2024+4.63%
Report Date
Nov 14, 2024
EPS Beat/Miss
+0.0%
Price Before
$2.81
Price After
$2.94
Q3 FY2024+1.46%
Report Date
Aug 14, 2024
EPS Beat/Miss
-15.8%
Price Before
$2.06
Price After
$2.09
Avg Beat Reaction-3.21%
Avg Miss Reaction-0.05%
Beat Rate4 / 8 quarters
Largest Move-7.17% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: GNLX ends December
Genelux Corporation (GNLX) most recently reported earnings on May 7, 2026 for Q2 FY2026, posting EPS of $-0.20 — missing the analyst consensus of $-0.18 by -11.1%. The next GNLX earnings date is expected around September 1, 2026.
Each quarter, investors track GNLX earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. GNLX revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
GNLX's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
GNLX earnings · 5 questionsGenelux Corporation's next earnings report is expected around September 1, 2026. GNLX typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; GNLX historically reports after market close (AMC).
GNLX earnings datewhen is GNLX earningsGNLX next earnings datewhen does GNLX report earningsGNLX earnings calendar
▸ Source: FMP · Genelux Corporation SEC filings · US GAAP · Genelux Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026